Personalizing Risk for Sudden Cardiac Death among Patients with Dilated Cardiomyopathies: Moving beyond Ejection Fraction with Genomics

Sadiya S. Khan; Jane E. Wilcox

doi:10.1001/jamacardio.2021.1116

Personalizing Risk for Sudden Cardiac Death among Patients with Dilated Cardiomyopathies: Moving beyond Ejection Fraction with Genomics

Sadiya S. Khan, Jane E. Wilcox^*

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Editorial › peer-review

Original language	English (US)
Pages (from-to)	873-874
Number of pages	2
Journal	JAMA cardiology
Volume	6
Issue number	8
DOIs	https://doi.org/10.1001/jamacardio.2021.1116
State	Published - Aug 2021

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1001/jamacardio.2021.1116

Cite this

@article{9db497d46025440abf484729f374e133,

title = "Personalizing Risk for Sudden Cardiac Death among Patients with Dilated Cardiomyopathies: Moving beyond Ejection Fraction with Genomics",

author = "Khan, {Sadiya S.} and Wilcox, {Jane E.}",

note = "Funding Information: reports receiving grants from the American Heart Association and the National Institutes of Health during the conduct of the study and outside of the submitted work. Dr Wilcox reports receiving consulting fees and honoraria from Amgen, Boerhinger Ingelheim, and Abbott and serves on the scientific advisory board for Cytokinetics.",

year = "2021",

month = aug,

doi = "10.1001/jamacardio.2021.1116",

language = "English (US)",

volume = "6",

pages = "873--874",

journal = "JAMA Cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - Personalizing Risk for Sudden Cardiac Death among Patients with Dilated Cardiomyopathies

T2 - Moving beyond Ejection Fraction with Genomics

AU - Khan, Sadiya S.

AU - Wilcox, Jane E.

N1 - Funding Information: reports receiving grants from the American Heart Association and the National Institutes of Health during the conduct of the study and outside of the submitted work. Dr Wilcox reports receiving consulting fees and honoraria from Amgen, Boerhinger Ingelheim, and Abbott and serves on the scientific advisory board for Cytokinetics.

PY - 2021/8

Y1 - 2021/8

UR - http://www.scopus.com/inward/record.url?scp=85106410758&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85106410758&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2021.1116

DO - 10.1001/jamacardio.2021.1116

M3 - Editorial

C2 - 33978671

AN - SCOPUS:85106410758

VL - 6

SP - 873

EP - 874

JO - JAMA Cardiology

JF - JAMA Cardiology

SN - 2380-6583

IS - 8

ER -

Personalizing Risk for Sudden Cardiac Death among Patients with Dilated Cardiomyopathies: Moving beyond Ejection Fraction with Genomics

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this